Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Pacs Group Insider Sold Shares Worth $5,614,667, According to a Recent SEC Filing

Pacs Group Insider Sold Shares Worth $5,614,667, According to a Recent SEC Filing

MT newswireMT newswire2026/10/19 08:05
04:05 AM EDT, 10/19/2026 (MT Newswires) -- Jason Hulse Murray, 10% Owner, Director, Co-Founder, Chief Executive Officer and Chairman, on October 14, 2026, sold 118,729 shares in Pacs Group (PACS) for $5,614,667. Following the Form 4 filing with the SEC, Murray has control over a total of 54,316,520 common shares of the company, with 54,316,520 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/2001184/000201438626000020/xslF345X05/wk-form4_1792188029.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.

NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.

华尔街见闻•2026/11/09 22:12